This is a sole-source, firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Speed Biosystems, LLC, a minority-owned, small disadvantaged business. The $248,980.00 contract is for the delivery of 78 units of TURBO293 Transfection Reagents to support coronavirus research, vaccine production, and immunogen development at NIAID facilities in Maryland. The award is not set aside and...
This is a sole-source purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The $146,860.00 firm-fixed-price contract is for the delivery of 46 units of TURBO293 Transfection Reagents, a specialized biological product used in coronavirus-related research, vaccine production, and immunogen development. The contract supports critical...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a small disadvantaged business, for the provision of 50 units of the company's TURBO293 transfection reagent at a total value of $148,325. The contract supports COVID-19 research at the Vaccine Research Center within NIAID. The requirement was sole-sourced to Speed Biosystems as the proprietary developer of the...
This federal contract award was made by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned, small disadvantaged business. The $146,750.00 firm fixed price purchase order is for the delivery of 70 units of Speed Biosystems' proprietary TURBO293 transfection reagent, which is critical for coronavirus-related research, vaccine development, and production of...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $222,712.50 firm fixed price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of 75 units of TURBO293 Transfection Reagent (20ML), catalog #PXX1002. This sole-source award was made on July 25, 2022 with a period of performance through July 24, 2023. The contract is not associated with...
This is a federal contract award by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Speed Biosystems, LLC, a minority-owned, small disadvantaged business. The $96,753.00 firm fixed-price purchase order is for the supply of 20mL of TURBO293 Transfection Reagent, a specialized biological research product used in coronavirus-related research, vaccine production, and immunogen development. The contract has no set-aside...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned, small disadvantaged business, for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The $146,600.00 contract was...
This contract is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents. The potential value of the contract is $146,750.00. The contract was sole-sourced to Speed Biosystems as the proprietary developer of the TURBO293 reagents, which...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, to provide 70 units of TURBO293 transfection reagent at a potential value of $146,750.00. The contract supports COVID-19 research and vaccine production activities at NIH labs in Maryland. This sole-source award was made under the...
This is a $248,980 firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The contract is for the supply of Speed Biosystems' proprietary TURBO293 Transfection Reagent, which is a critical product supporting coronavirus-related research, vaccine production, and the development of immunogens and...